Discover Nidra, now granted FDA market authorization with controlled release coming soon!
Nidra is the first and only drug-free wearable therapy, clinically proven to reduce symptoms of Restless Leg Syndrome (RLS) when prescription medication is not providing relief.
1. Lipford MC, Silber MH. Sleep Med. 2012;13(10):1280-1285. 2. Silver N, et al. Sleep Med. 2011;12(5):440-444. 3. Meyers J, et al. Manag Care. 2012;21(10):44-51. 4. Kushida CA, et al. Neurology. 2009;72(5):439-446.
1. Buchfuhrer MJ et al. J Clin Sleep Med. 2021;17(8):1685-1694.
The safety and efficacy of Nidra was evaluated in people with moderate-severe RLS who are resistant to medications in the RESTFUL study and in a subsequent 6-month extension study.1,2
reported an
improvement in
their symptoms
over 8 weeks.
reported acute
improvement in their
symptoms following
individual sessions.
symptom-free
per month.
Nidra provides relief with ZERO serious device-related adverse events reported at 6 months.
1. Safety and efficacy were determined based on enrollment of 133 participants in the RESTFUL study and 44 participants in the 6-month extension study.
2. Noctrix Health. Data on File. CL-10 Report, Analysis of acute relief from NTX100 TOMAC.
If prescription medications aren’t bringing you relief, talk with your doctor about Nidra, the drug-free solution to manage your RLS symptoms.
of people reported an improvement
in their symptoms over 8 weeks.
of people reported an improvement
in their symptoms over 8 weeks.
INDICATION
The NTX100 Tonic Motor Activation (TOMAC) System is intended to reduce symptoms of primary moderate-severe Restless Legs Syndrome and to improve sleep quality in adults refractory to medications.*
Rx Only. Caution: Federal law restricts this device to sale by or on the order of a medical professional.
*FDA De Novo Number DEN220059
© 2023 Noctrix Health, Inc. All rights reserved.
MKT-8 Rev 2.0
All information on this website is provided for informational purposes only and is not intended to be a substitute for any professional medical advice or any medical diagnosis or treatment. Nidra is intended for prescription use only and is only available for commercial sale in the United States by or on the order of a physician. Individual patient experience may vary.
IMPORTANT SAFETY INFORMATION
Contraindications
The Nidra TOMAC System is contraindicated for use in patients with the following:
Potential Complications
There is a potential for the following side effects, which are typically mild to moderate and resolve over time:
This list is not all inclusive. Please refer to the Instructions for Use. for all of the important warnings and precautions before using or prescribing this product.